The role of 18fluoro-deoxy glucose combined position emission and computed tomography in the clinical management of anal squamous cell carcinoma

Colorectal Disease

Volumn 13, Issue 5, 2011, Pages 532-537

  Engledow, A H ^a   Skipworth, J R A ^a   Blackman, G ^a   Groves, A ^a   Bomanji, J ^a   Warren, S J ^b   Ell, P J ^a   Boulos, P B ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b CHASE FARM HOSPITAL   (United Kingdom)

Author keywords

18 Fluoro deoxy glucose; Anal carcinoma; PETCT; Staging

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; MITOMYCIN;

ADULT; AGED; ANUS CARCINOMA; ARTICLE; ASPIRATION BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER CYTODIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; INGUINAL LYMPH NODE; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; WHOLE BODY CT; WHOLE BODY PET; ANUS TUMOR; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE MANAGEMENT; METHODOLOGY; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; DISEASE MANAGEMENT; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79953308867     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2010.02193.x     Document Type: Article

References (40)

1. Parkin DM, Whelan SL, Ferlay J et al.. (2002) Cancer Incidence in Five Continents. IARC Scientific Publication No. 155, VIII. Lyons: International Agency for Research on Cancer.
2. Karandikar SS, Borley A, Crosby T, Williams G, Reynolds S, Radcliffe AG. A five-year audit of anal cancer in Wales. Colorectal Dis 2006; 8: 266-72.
3. Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 2004; 101: 281-8.
4. Brewster DH, Bhatti LA. Increasing incidence of squamous cell carcinoma of the anus in Scotland, 1975-2002. Br J Cancer 2006; 95: 87-90.
5. Daling JR, Madeleine MM, Johnson LG et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004; 101: 270-80.
6. Frisch M, Glimelius B, van den Brule AJ et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337: 1350-8.
7. Frisch M, Glimelius B, Wohlfahrt J, Adami HO, Melbye M et al. Tobacco smoking as a risk factor in anal carcinoma: an antiestrogenic mechanism? J Natl Cancer Inst 1999; 91: 708-15.
8. Chawla AK, Willett CG. Squamous cell carcinoma of the anal canal and anal margin. Hematol Oncol Clin North Am 2001; 15: 321-44, vi.
9. Deans GT, McAleer JJ, Spence RA. Malignant anal tumours. Br J Surg 1994; 81: 500-8.
10. Lorenz HP, Wilson W, Leigh B, Crombleholme T, Schecter W. Squamous cell carcinoma of the anus and HIV infection. Dis Colon Rectum 1991; 34: 336-8.
11. Goldman S, Glimelius B, Glas U, Lundell G, Påhlman L, Ståhle E. Management of anal epidermoid carcinoma-an evaluation of treatment results in two population-based series. Int J Colorectal Dis 1989; 4: 234-43.
12. Papillon J, Montbarbon JF. Epidermoid carcinoma of the anal canal. A series of 276 cases. Dis Colon Rectum 1987; 30: 324-33.
13. Myerson RJ, Kong F, Birnbaum EH et al. Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome. Radiother Oncol 2001; 61: 15-22.
14. Cummings BJ, Keane TJ, O'Sullivan B, Wong CS, Catton CN. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 1991; 21: 1115-25.
15. Touboul E, Schlienger M, Buffat L et al. Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients. Cancer 1994; 73: 1569-79.
16. Bai YK, Cao WL, Gao JD, Liang J, Shao YF. Surgical salvage therapy of anal cancer. World J Gastroenterol 2004; 10: 424-6.
17. Roohipour R, Patil S, Goodman KA et al. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Dis Colon Rectum 2008; 51: 147-53.
18. Frost DB, Richards PC, Montague ED, Giacco GG, Martin RG. Epidermoid cancer of the anorectum. Cancer 1984; 53: 1285-93.
19. Papathanassiou D, Bruna-Muraille C, Liehne JC, Nguyen TD, Curé H. Positron emission tomography in oncology: Present and future of PET and PET/CT. Crit Rev Oncol Hematol, 2009; 73: 239-54.
20. Goerres GW, Kamel E, Seifert B et al. Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system. J Nucl Med 2002; 43: 1469-75.
21. Tann MA, Fletcher JW, McHenry L et al. FDG-PET/CT in the evaluation of cystic pancreatic tumours: comparison with endoscopic ultrasound fine needle aspiration. J Nucl Med 2003; 44: 24.
22. 18F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 2003; 44: 1797-803.
23. Gutte H, Højgaard L, Kjaer A. Early clinical experience and impact of 18F-FDG PET. Nucl Med Commun 2005; 26: 989-94.
24. Nguyen BT, Joon DL, Khoo V et al. Assessing the impact of FDG-PET in the management of anal cancer. Radiother Oncol 2008; 87: 376-82.
25. Cotter SE, Grigsby PW, Siegel BA et al. FDG-PET/CT in the evaluation of anal carcinoma. Int J Radiat Oncol Biol Phys 2006; 65: 720-5.
26. Scherrer A, Reboul F, Martin D, Dupuy JC, Menu Y. CT of malignant anal canal tumors. Radiographics 1990; 10: 433-53.
27. Winton E, Heriot AG, Ng M et al. The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer. Br J Cancer 2009; 100: 693-700.
28. Trautmann TG, Zuger JH. Positron emission tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal. Mol Imaging Biol 2005; 7: 309-13.
29. Iagaru A, Kundu R, Jadvar H, Nagle D. Evaluation by 18F-FDG-PET of patients with anal squamous cell carcinoma. J Nucl Med 2009; 12: 26-9.
30. Mistrangelo M et al. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer. Int J Radiat Oncol Biol Phys 2010; 77: 73-78.
31. Drieskens O, Oyen R, Van Poppel H, Vankan Y, Flamen P, Mortelmans L. FDG-PET for preoperative staging of bladder cancer. Eur J Nucl Med Mol Imaging 2005; 32: 1412-7.
32. Grigsby PW, Siegel BA, Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 2001; 19: 3745-9.
33. Sato H, Koh PK, Bartolo DC. Management of anal canal cancer. Dis Colon Rectum 2005; 48: 1301-15.
34. Gerard JP, Chapet O, Samiei F et al. Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature. Cancer 2001; 92: 77-84.
35. Wade DS, Herrera L, Castillo NB, Petrelli NJ. Metastases to the lymph nodes in epidermoid carcinoma of the anal canal studied by a clearing technique. Surg Gynecol Obstet 1989; 169: 238-42.
36. Nguyen BD, Ram PC, Roarke MC. F-18 FDG PET/CT imaging of anal canal squamous cell carcinoma. Clin Nucl Med 2007; 32: 234-6.
37. Piperkova E, Raphael B, Altinyay M et al. Impact of PET/CT on initial staging, restaging and treatment management of anal cancer: a clinical case with literature review. J BUON, 2006; 11: 523-7.
38. Ciernik IF, Dizendorf E, Baumert BG et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys 2003; 57: 853-63.
39. Anderson C, Koshy M, Staley C et al. PET-CT fusion in radiation management of patients with anorectal tumors. Int J Radiat Oncol Biol Phys 2007; 69: 155-62.
40. Schwarz JK, Siegel BA, Dehdashti F, Myerson RJ, Fleshman JW, Grigsby PW. Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer. Int J Radiat Oncol Biol Phys 2008; 71: 180-6.